| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $6.57 (Beat by $0.03) |
| EPS GAAP Actual | $6.57 (Beat by $0.03) |
| Revenue Actual | $4.30153B |
| Revenue Surprise | Beat by $4301.53M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $4.94 |
| EPS GAAP Estimate | $4.94 |
| Revenue Estimate | $3.9124B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 2 |
| Dec 2027 | 27.19358 | 28.54 | 26.83234 | 27.60234 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 6.59 | 6.59 | 4.30153B | 14.06% | 4301.53M |
| FQ2 2025 (Jun 2025) | 6.74 | 6.74 | 4.3044B | 14.81% | 4304.4M |
| FQ1 2025 (Mar 2025) | 5.27 | 5.27 | 3.86737B | 11.25% | 3867.37M |
| FQ4 2024 (Dec 2024) | 6.35 | 6.35 | 3.77002B | 8.77% | 3770.02M |
| FQ3 2024 (Sep 2024) | 5.75 | 5.75 | 3.69692B | 13.24% | 3696.92M |
| FQ2 2024 (Jun 2024) | 5.27 | 5.27 | 3.6669B | 16.94% | 3666.9M |
| FQ1 2024 (Mar 2024) | 4.18 | 4.18 | 3.43228B | 15.79% | 3432.28M |
| FQ4 2023 (Dec 2023) | 0.0045 | 0.0045 | 3.43922B | 14.23% | 3439.22M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
4.94
Consensus Revenue Estimates
3.9124B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 7.97618 | -- | 7.89619 | 8.02654 | 1 |
| FQ3 2027 (Sep 2027) | 8.18498 | -- | 8.10289 | 8.23666 | 1 |
| FQ2 2027 (Jun 2027) | 7.69591 | -- | 7.61873 | 7.7445 | 1 |
| FQ1 2027 (Mar 2027) | 6.29169 | -- | 6.22859 | 6.33141 | 1 |
| FQ4 2026 (Dec 2026) | 7.4971 | -- | 7.42191 | 7.54444 | 1 |
| FQ3 2026 (Sep 2026) | 7.43959 | 11.42 | 7.36498 | 7.48656 | 1 |
| FQ2 2026 (Jun 2026) | 7.18933 | 6.25 | 7.11723 | 7.23472 | 1 |
| FQ1 2026 (Mar 2026) | 4.94 | -6.68 | 4.93696 | 4.94304 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 4.72B | -- | 4.68B | 4.74B | 2 |
| FQ3 2027 (Sep 2027) | 4.77B | -- | 4.73B | 4.79B | 2 |
| FQ2 2027 (Jun 2027) | 4.75B | -- | 4.71B | 4.77B | 2 |
| FQ1 2027 (Mar 2027) | 4.35B | -- | 4.31B | 4.37B | 2 |
| FQ4 2026 (Dec 2026) | 4.54B | -- | 4.51B | 4.56B | 2 |
| FQ3 2026 (Sep 2026) | 4.56B | 5.61 | 4.52B | 4.58B | 2 |
| FQ2 2026 (Jun 2026) | 4.54B | 5.2 | 4.51B | 4.56B | 2 |
| FQ1 2026 (Mar 2026) | 3.91B | 1.15 | 3.91B | 3.91B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 6.59 | 6.59 | 100% | |
| FQ2 2025 (Jun 2025) | 6.74 | 6.74 | 100% | |
| FQ1 2025 (Mar 2025) | 5.27 | 5.27 | 100% | |
| FQ4 2024 (Dec 2024) | 6.35 | 6.35 | 100% | |
| FQ3 2024 (Sep 2024) | 5.75 | 5.75 | 100% | |
| FQ2 2024 (Jun 2024) | 5.27 | 5.27 | 100% | |
| FQ1 2024 (Mar 2024) | 4.18 | 4.18 | 100% | |
| FQ4 2023 (Dec 2023) | 0.0045 | 0.0045 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $4.3B | $4301.53M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $4.3B | $4304.4M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $3.87B | $3867.37M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.77B | $3770.02M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.7B | $3696.92M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.67B | $3666.9M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.43B | $3432.28M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $3.44B | $3439.22M | 100% |